Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade

Cited by (1,000)

Items 501–600 of 1,000

1. Immunological cure of HBV infection
   Julia Lang‐Meli, Christoph Neumann‐Haefelin, Robert Thimme · 2019 · Hepatology International
2. Common gamma chain cytokines and CD8 T cells in cancer
   Mitra Shourian, Jean‐Christophe Beltra, Benoîte Bourdin, Hélène Decaluwe · 2019 · Seminars in Immunology
3. Modulation of SRSF2 expression reverses the exhaustion of TILs via the epigenetic regulation of immune checkpoint molecules
   Ziqiang Wang, Kun Li, Wei Chen, Xiaoxia Wang, Yikun Huang, Wei‐Ming Wang, Wanjun Wu, Zhiming Cai, Weiren Huang · 2019 · Cellular and Molecular Life Sciences
4. Epigenetics and CD8+ T cell memory*
   Gaia Montacchiesi, Luigia Pace · 2021 · Immunological Reviews
5. A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy
   H. Josh Jang, Galen H. Hostetter, Alexander W. Macfarlane, Zachary Madaj, Eric A. Ross, Toshinori Hinoue, Justin R. Kulchycki, Ryan S. Burgos, Mahvish Tafseer, R. Katherine Alpaugh et al. · 2023 · Clinical Cancer Research
6. Landscapes and mechanisms of CD8+ T cell exhaustion in gastrointestinal cancer
   Jiatong Ding, Kangping Yang, Haonan Zhou, Ying-Feng Huang, Hui Li, Zhen Zong · 2023 · Frontiers in Immunology
7. Challenges to a Cure for HBV Infection
   Barbara Testoni, Massimo Levrero, Fabien Zoulim · 2017 · Seminars in Liver Disease
8. Viral hepatitis, inflammation, and cancer: A lesson for autoimmunity
   Silvia Piconese, Ilenia Cammarata, Vincenzo Barnaba · 2018 · Journal of Autoimmunity
9. Organoid technology and applications in cancer immunotherapy and precision medicine
   Krisztián Homicskó · 2020 · Current Opinion in Biotechnology
10. Anti-PD1 therapy induces lymphocyte-derived exosomal miRNA-4315 release inhibiting Bim-mediated apoptosis of tumor cells
    Nina Guyon, Delphine Garnier, Joséphine Briand, Arulraj Nadaradjane, Gwenola Bougras-Cartron, Judith Raimbourg, Mario Campone, Dominique Heymann, François M. Vallette, Jean‐Sébastien Frenel et al. · 2020 · Cell Death and Disease
11. Landscape and Dynamics of the Transcriptional Regulatory Network During Natural Killer Cell Differentiation
    Kun Li, Yang Wu, Young Li, Qiaoni Yu, Tian Zhigang, Haiming Wei, Kun Qu · 2020 · Genomics Proteomics & Bioinformatics
12. Emerging dynamics pathways of response and resistance to PD-1 and CTLA-4 blockade: tackling uncertainty by confronting complexity
    Allan Relecom, Maysaloun Merhi, Varghese Philipose Inchakalody, Shahab Uddin M.S., Darawan Rinchai, Davide Bedognetti, Said Dermime · 2021 · Journal of Experimental & Clinical Cancer Research
13. Targeting BMI-1 in B cells restores effective humoral immune responses and controls chronic viral infection
    Andrea Di Pietro, Jack Polmear, Lucy Cooper, Timon Damelang, Tabinda Hussain, Lauren Hailes, Kristy O’Donnell, Vibha Udupa, Mi Tian, Simon Preston et al. · 2021 · Nature Immunology
14. How metabolism bridles cytotoxic CD8+ T cells through epigenetic modifications
    Heleen H. Van Acker, Shixin Ma, Tommaso Scolaro, Susan M. Kaech, Massimiliano Mazzone · 2021 · Trends in Immunology
15. Recruit or Reboot? How Does Anti-PD-1 Therapy Change Tumor-Infiltrating Lymphocytes?
    Margaret K. Callahan, Jedd D. Wolchok · 2019 · Cancer Cell
16. Intimate communications within the tumor microenvironment: stromal factors function as an orchestra
    Bing Cheng, Qiang Yu, Wenyu Wang · 2023 · Journal of Biomedical Science
17. Reprogramming the anti-tumor immune response via CRISPR genetic and epigenetic editing
    Eric Alves, Shahama Taifour, Riccardo Dolcetti, Jonathan Chee, Anna K. Nowak, Silvana Gaudieri, Pilar Blancafort · 2021 · Molecular Therapy — Methods & Clinical Development
18. Impacts of neoadjuvant chemoradiotherapy on the immune landscape of esophageal squamous cell carcinoma
    Jing Wen, Shuogui Fang, Yi Hu, Mian Xi, Zelin Weng, Chuqing Pan, Kongjia Luo, Yihong Ling, Renchun Lai, Xiuying Xie et al. · 2022 · EBioMedicine
19. Immune checkpoint inhibitors and reproductive failures
    Zeyang Chen, Jinxia Huang, Joanne Y-H Kwak-Kim, Wenjuan Wang · 2023 · Journal of Reproductive Immunology
20. Overcoming Antigen Escape and T-Cell Exhaustion in CAR-T Therapy for Leukemia
    Elżbieta Bartoszewska, Maciej Tota, Monika Kisielewska, Izabela Skowron, Kamil Sebastianka, Oliwia Stefaniak, Klaudia Molik, Jakub Rubin, Karolina Kraska, Anna Choromańska · 2024 · Cells
21. Mechanisms of Resistance to Checkpoint Blockade Therapy
    Hubing Shi, Jiang Lan, Jiqiao Yang · 2020 · Advances in experimental medicine and biology
22. Bromodomain protein BRD4 directs and sustains CD8 T cell differentiation during infection
    J. Justin Milner, Clara Toma, Sara Quon, Kyla D. Omilusik, Nicole E. Scharping, Anup Dey, Miguel Reina‐Campos, Hongtuyet Nguyen, Adam J. Getzler, Huitian Diao et al. · 2021 · The Journal of Experimental Medicine
23. T-cell Exhaustion in Organ Transplantation
    Andrea Angeletti, Chiara Cantarelli, Leonardo V. Riella, Miguel Fribourg, Paolo Cravedi · 2021 · Transplantation
24. Functional Exhaustion of HBV-Specific CD8 T Cells Impedes PD-L1 Blockade Efficacy in Chronic HBV Infection
    Sara Ferrando‐Martínez, Angie Snell Bennett, Elisabete Lino, Adam J. Gehring, Jordan J. Feld, Harry L.A. Janssen, Scott H. Robbins · 2021 · Frontiers in Immunology
25. Spatial determinants of CD8+ T cell differentiation in cancer
    Katherine Tooley, Giulia Escobar, Ana Carrizosa Anderson · 2022 · Trends in cancer
26. TET2 regulates early and late transitions in exhausted CD8 + T cell differentiation and limits CAR T cell function
    Alexander J. Dimitri, Amy E. Baxter, Gregory M. Chen, Caitlin R. Hopkins, Geoffrey T. Rouin, Hua Huang, Weimin Kong, Christopher Holliday, Volker Wiebking, Robert L. Bartoszek et al. · 2024 · Science Advances
27. Pretreatment Innate Cell Populations and CD4 T Cells in Blood Are Associated With Response to Immune Checkpoint Blockade in Melanoma Patients
    Pirozyan, Mehdi R., McGuire, Helen M., Emran, Abdullah Al, Tseng, Hsin-Yi, Tiffen, Jessamy C., Lee, Jenny H., Carlino, Matteo S., Menzies, Alexander M., Long, Georgina V., Scolyer, Richard A. et al. · 2020 · Frontiers in Immunology
28. Epigenetic mechanisms of tumor resistance to immunotherapy
    Arenas-Ramirez, Natalia, Sahin, Dilara, Boyman, Onur · 2018 · Cellular and Molecular Life Sciences
29. Overcoming resistance to PD-1 and CTLA-4 blockade mechanisms and therapeutic strategies
    Xiaodong Wang, Jing Na He, Gouping Ding, Yixuan Tang, Qianqian Wang · 2025 · Frontiers in Immunology
30. PD-1 Expression during Acute Infection Is Repressed through an LSD1–Blimp-1 Axis
    Alexander P. R. Bally, Dennis Kyle Neeld, Peiyuan Lu, Parimal Majumder, Yan Tang, Benjamin G. Barwick, Qing Wang, Jeremy M. Boss · 2019 · The Journal of Immunology
31. Glucometabolic Reprogramming in the Hepatocellular Carcinoma Microenvironment: Cause and Effect
    Huining Tian, Xiaoyu Zhu, You Lv, Yan Jiao, Guixia Wang · 2020 · Cancer Management and Research
32. Mechanisms of immunogenic cell death and immune checkpoint blockade therapy
    Richard A. Lin, Jessica K. Lin, Shiaw‐Yih Lin · 2021 · The Kaohsiung Journal of Medical Sciences
33. The development of CD8 T-cell exhaustion heterogeneity and the therapeutic potentials in cancer
    Junfeng Zhang, Feifei Lei, Huabing Tan · 2023 · Frontiers in Immunology
34. Deep learning identifies a T-cell exhaustion-dependent transcriptional signature for predicting clinical outcomes and response to immune checkpoint blockade
    Zicheng Zhang, Hongyan Chen, Dongxue Yan, Lu Chen, Jie Sun, Meng Zhou · 2023 · Oncogenesis
35. Targeting SPHK1 in macrophages remodels the tumor microenvironment and enhances anti‐PD‐1 immunotherapy efficacy in colorectal cancer liver metastasis
    Yizhi Zhan, XU Jin-song, Zhanqiao Zhang, Yating Hu, Yongsheng Li, Junying Qian, Yunyan Ling, Dehua Wu, Haijun Deng, Guoxin Li et al. · 2025 · 癌症：英文版
36. Epigenetic modulation of immunotherapy and implications in head and neck cancer
    Liye Zhou, Na Xu, Hirofumi Shibata, Vassiliki Saloura, Ravindra Uppaluri · 2021 · Cancer and Metastasis Reviews
37. CD40 Agonist Overcomes T Cell Exhaustion Induced by Chronic Myeloid Cell IL-27 Production in a Pancreatic Cancer Preclinical Model
    Adam L. Burrack, Meagan R. Rollins, Ellen J. Spartz, Taylor D. Mesojednik, Zoe C. Schmiechen, Jackson F. Raynor, Iris Wang, Ross M. Kedl, Ingunn M. Stromnes · 2021 · The Journal of Immunology
38. Restoration of a functional antiviral immune response to chronic HBV infection by reducing viral antigen load: if not sufficient, is it necessary?
    Sisi Yang, Wanjia Zeng, Jiming Zhang, Fengmin Lu, Jinhong Chang, Ju‐Tao Guo · 2021 · Emerging Microbes & Infections
39. Early β‐amyloid accumulation in the brain is associated with peripheral T cell alterations
    Christoph Gericke, Tunahan Kirabali, Roman Flury, Anna Mallone, Chiara Rickenbach, Luka Kulic, Vinko Toševski, Christoph Höck, Roger M. Nitsch, Valérie Treyer et al. · 2023 · Alzheimer s & Dementia
40. Widespread B cell perturbations in HIV-1 infection afflict naive and marginal zone B cells
    Thomas Liechti, Claus Kadelka, Dominique L. Braun, Herbert Kuster, Jürg Böni, Melissa Robbiani, Huldrych F. Günthard, Alexandra Trkola · 2019 · The Journal of Experimental Medicine
41. Learning from the nexus of autoimmunity and cancer
    Mangani, Davide, Yang, Dandan, Anderson, Ana C. · 2023 · Immunity
42. Galectin-3 induces pathogenic immunosuppressive macrophages through interaction with TREM2 in lung cancer
    Qiaohua Wang, Yongjian Wu, Guanmin Jiang, Xi Huang · 2024 · Journal of Experimental & Clinical Cancer Research
43. Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodies
    Felipe Gálvez‐Cancino, Mariela Navarrete, Gordon Beattie, Simone Puccio, Enrique Conde, Kane A. Foster, Yasmin Morris, Teerapon Sahwangarrom, Despoina Karagianni, Jiali Liu et al. · 2025 · Immunity
44. Can Immunogenic Chemotherapies Relieve Cancer Cell Resistance to Immune Checkpoint Inhibitors?
    Thaiz Rivera Vargas, Lionel Apétoh · 2019 · Frontiers in Immunology
45. Dual Relief of T-lymphocyte Proliferation and Effector Function Underlies Response to PD-1 Blockade in Epithelial Malignancies
    Camille-Charlotte Balança, Clara‐Maria Scarlata, Marie Michelas, Christel Devaud, Victor Sarradin, Camille Franchet, Carlos Gomez‐Roca, Carlos Gomez‐Roca, Marie Tosolini, Diana Heaugwane et al. · 2020 · Cancer Immunology Research
46. Persistence of self-reactive CD8+ T cells in the CNS requires TOX-dependent chromatin remodeling
    Nicolas Pagé, Sylvain Lemeille, Ilena Vincenti, Bogna Klimek, Alexandre Mariotte, Ingrid Wagner, Giovanni Di Liberto, Jonathan Kaye, Doron Merkler · 2021 · Nature Communications
47. PD-1 blockade prevents the progression of oral carcinogenesis
    Yunmei Dong, Zhen Wang, Fei Mao, Luyao Cai, Hongxia Dan, Lu Jiang, Xin Ying Zeng, Taiwen Li, Yu Jerry Zhou, Qianming Chen · 2021 · Carcinogenesis
48. PD-1 signalling defines and protects leukaemic stem cells from T cell receptor-induced cell death in T cell acute lymphoblastic leukaemia
    Xi Xu, Wen‐Wen Zhang, Li Xuan, Yanhui Yu, Wen Zheng, Tao Fang, Jacqelyn M. Nemechek, Chong He, Weiwei Ma, Xue Na Han et al. · 2023 · Nature Cell Biology
49. Optimizing therapy in advanced-stage Hodgkin lymphoma
    Sean H. Lim, Peter Johnson · 2018 · Blood
50. NR4A1 transcriptionally regulates the differentiation of stem-like CD8+ T cells in the tumor microenvironment
    Jing Hao, Ruifeng Li, Xiaohong Zhao, Xinwei Liu, Xiang Chen, Tian Xie, Xiaoli Li, Chenjun Yao, Qinli Sun, Kun Wei et al. · 2024 · Cell Reports
51. Exhaustion and Inflation at Antipodes of T Cell Responses to Chronic Virus Infection
    Luka Čičin‐Šain, Ramon Arens · 2017 · Trends in Microbiology
52. Reversal of T Cell Exhaustion in Chronic HCV Infection
    Sylwia Osuch, Karin Jutta Metzner, Kamila Caraballo Cortés · 2020 · Viruses
53. Adoptive T Cell Therapy with IL-12–Preconditioned Low-Avidity T Cells Prevents Exhaustion and Results in Enhanced T Cell Activation, Enhanced Tumor Clearance, and Decreased Risk for Autoimmunity
    Christopher Tucker, Jason S. Mitchell, Tijana Martinov, Brandon J. Burbach, Lalit K. Beura, Joseph C Wilson, Alexander J. Dwyer, Lovejot M. Singh, Matthew F. Mescher, Brian T. Fife · 2020 · The Journal of Immunology
54. Hybrid Fc‐fused interleukin‐7 induces an inflamed tumor microenvironment and improves the efficacy of cancer immunotherapy
    Ji‐Hae Kim, Young‐Min Kim, Donghoon Choi, Saet-Byeol Jo, Han Wook Park, Sung‐Wook Hong, Sujeong Park, Sora Kim, Sookjin Moon, Gihoon You et al. · 2020 · Clinical & Translational Immunology
55. NFAT-dependent and -independent exhaustion circuits program maternal CD8 T cell hypofunction in pregnancy
    Emma L. Lewis, Rong Xu, Jean‐Christophe Beltra, Shin Foong Ngiow, Jordana B. Cohen, Rahul Telange, Alexander Crane, Deirdre L. Sawinski, E. John Wherry, Paige M. Porrett · 2021 · The Journal of Experimental Medicine
56. Dietary restriction reprograms CD8+ T cell fate to enhance anti-tumour immunity and immunotherapy responses
    Brandon M. Oswald, Lisa M. DeCamp, Joseph Longo, Michael S. Dahabieh, Nicholas Bunda, Benjamin K. Johnson, McLane J. Watson, Shixin Ma, Samuel E.J. Preston, Ryan D. Sheldon et al. · 2025 · Nature Metabolism
57. Overcoming CD8+ T-Cell Exhaustion in Viral Hepatitis: Lessons from the Mouse Model and Clinical Perspectives
    Dominik Wieland, Maike Hofmann, Robert Thimme · 2017 · Digestive Diseases
58. Epigenetic Strategies to Boost Cancer Immunotherapies
    María J. Barrero · 2017 · International Journal of Molecular Sciences
59. Targeting Toll-like receptor 3 in dendritic cells for cancer immunotherapy
    Misako Matsumoto, Yohei Takeda, Tsukasa Seya · 2020 · Expert Opinion on Biological Therapy
60. CAR T Cell Therapy Progress and Challenges for Solid Tumors
    Lawrence A. Stern, Vanessa D. Jönsson, Saul J. Priceman · 2020 · Cancer treatment and research
61. CTLA4 promoter methylation predicts response and progression-free survival in stage IV melanoma treated with anti-CTLA-4 immunotherapy (ipilimumab)
    Simon Fietz, Romina Zarbl, Dennis Niebel, Christian Posch, Peter Brossart, Gerrit H. Gielen, Sebastian Strieth, Torsten Pietsch, Glen Kristiansen, Friedrich Bootz et al. · 2020 · Cancer Immunology Immunotherapy
62. Applications of Single-Cell Omics to Dissect Tumor Microenvironment
    Tingting Guo, Weimin Li, Xuyu Cai · 2020 · Frontiers in Genetics
63. Integrated single-cell profiling dissects cell-state-specific enhancer landscapes of human tumor-infiltrating CD8+ T cells
    Dania Riegel, Elena Romero-Fernández, Malte Simon, Akinbami Adenugba, Katrin Singer, Roman Mayr, Florian Weber, Mark Kleemann, Charles David Imbusch, Marina P Kreutz et al. · 2023 · Molecular Cell
64. The antitumor effects of entinostat in ovarian cancer require adaptive immunity
    Haller J. Smith, Tyler R. McCaw, Angelina I. Londoño, Ashwini A. Katre, Selene Meza‐Perez, Eddy Shih-Hsin Yang, Andres Forero, Donald J. Buchsbaum, Troy D. Randall, John Michael Straughn et al. · 2018 · Cancer
65. Cytokine signaling in chimeric antigen receptor T-cell therapy
    Yuki Kagoya · 2023 · International Immunology
66. Priming with LSD1 inhibitors promotes the persistence and antitumor effect of adoptively transferred T cells
    Fengqi Qiu, Peishan Jiang, Guiheng Zhang, Jie An, Kexin Ruan, Xiaowen Lyu, Jianya Zhou, Wanqiang Sheng · 2024 · Nature Communications
67. Epigenetic regulation of T cell exhaustion in cancer
    Tae Gun Kang, Jordan T. Johnson, Caitlin C. Zebley, Ben Youngblood · 2025 · Nature reviews. Cancer
68. The chronicles of T-cell exhaustion
    Robert A. Amezquita, Susan M. Kaech · 2017 · Nature
69. Interleukin 2 modulates thymic-derived regulatory T cell epigenetic landscape
    Laurent Chorro, Masako Suzuki, Shu Shien Chin, Tere M. Williams, Erik L. Snapp, Livia Odagiu, Nathalie Labrecque, Gregoire S. Lauvau · 2018 · Nature Communications
70. Global alteration of T-lymphocyte metabolism by PD-L1 checkpoint involves a block of de novo nucleoside phosphate synthesis
    Nicolaos Jay Palaskas, Jacob David Garcia, Roksana Shirazi, Daniel Sanghoon Shin, Cristina Puig-Saus, Daniel Braas, Antoni Ribas, Thomas G. Graeber · 2019 · Cell Discovery
71. DNA methylation regulates TIGIT expression within the melanoma microenvironment, is prognostic for overall survival, and predicts progression-free survival in patients treated with anti-PD-1 immunotherapy
    Dennis Niebel, Anne Fröhlich, Romina Zarbl, Simon Fietz, Luka de Vos, Timo Jakob Vogt, Jörn Dietrich, Judith D. Sirokay, Pia Kuster, Gonzalo Saavedra et al. · 2022 · Clinical Epigenetics
72. Single-cell atlas of diverse immune populations in the advanced biliary tract cancer microenvironment
    Xuebing Shi, Zhixuan Li, Ren-qi Yao, Qingbao Cheng, Wei Li, Rui Ting Wu, Zhihua Xie, Yanjing Zhu, Xinyao Qiu, Shuai Yang et al. · 2022 · npj Precision Oncology
73. Optimizing Treatment for Relapsed/Refractory Classic Hodgkin Lymphoma in the Era of Immunotherapy
    Michael P. Randall, Michael Alexander Spinner · 2023 · Cancers
74. Machine Learning Links T-cell Function and Spatial Localization to Neoadjuvant Immunotherapy and Clinical Outcome in Pancreatic Cancer
    Katie E. Blise, Shamilene Sivagnanam, Courtney B. Betts, Konjit Betre, Nell C. Kirchberger, Benjamin J. Tate, Emma Elizabeth Furth, Andressa Dias Costa, Jonathan Andrew Nowak, Brian Matthew Wolpin et al. · 2024 · Cancer Immunology Research
75. Anti-CTLA-4 generates greater memory response than anti-PD-1 via TCF-1
    Stephen Mok, Huey Liu, Didem Ağaç Çobanoğlu, Nana-Ama A.S. Anang, James J. Mancuso, E. John Wherry, James Patrick Allison · 2025 · Proceedings of the National Academy of Sciences
76. Mechanisms of Resistance to Anti-PD-1 Immunotherapy in Melanoma and Strategies to Overcome It
    Magdalena K. Zielińska, Magdalena A. Ciążyńska, Dorota Sulejczak, Piotr Lukasz Rutkowski, Anna Malgorzata Czarnecka · 2025 · Biomolecules
77. Regulation of T cell exhaustion and stemness: molecular mechanisms and implications for cancer immunotherapy
    Zeyu Chen, Ziang Zhu, Taidou Hu, Chen Yao, Tuoqi Wu · 2025 · Cellular and Molecular Immunology
78. Progress of immune checkpoint therapy in the clinic (Review)
    Yiqun Fan, Chi Zhang, Shengjie Jin, Zhihui Gao, Jun Cao, Aoqing Wang, Dawei Li, Qian Wang, Xing Sun, Dousheng Bai · 2018 · Oncology Reports
79. Clonal tracing reveals diverse patterns of response to immune checkpoint blockade
    Shengqing Stan Gu, Xiaoqing Wang, Xihao Sherlock Hu, Peng Jiang, Ziyi Li, Nicole C. Traugh, Xia Bu, Qin Tang, Chenfei Wang, Zexian Zeng et al. · 2020 · Genome biology
80. Nivolumab + Ipilimumab for patients with hepatocellular carcinoma previously treated with Sorafenib
    Josephine Tsang, Jeffrey Sum Lung Wong, Gin Wai Kwok, Bryan Cho Wing Li, Roland Ching-Yu Leung, Joanne Wing Yan Chiu, Tan To Cheung, Thomas C. C. Yau · 2021 · Expert Review of Gastroenterology & Hepatology
81. Neutrophils: Musketeers against immunotherapy
    Kashif Rafiq Zahid, Umar Raza, Soumya Tumbath, Lingxiang Jiang, Wenjuan Xu, Xiumei Huang · 2022 · Frontiers in Oncology
82. Leukemia cell-derived microvesicles induce T cell exhaustion via miRNA delivery
    Jieke Cui, Qing Li, Mei Luo, Zhaodong Zhong, Shu Zhou, Lin Jiang, Na Shen, Zhe Geng, Hui Wen Cheng, Meng Li et al. · 2018 · OncoImmunology
83. Enforcing the checkpoints: harnessing T-cell exhaustion for therapy of T1D
    Peter S. Linsley, Sarah Alice Long · 2019 · Current Opinion in Endocrinology Diabetes and Obesity
84. Low‐dose radiation therapy mobilizes antitumor immunity: New findings and future perspectives
    Laiyan Zhou, Yuanxin Liu, Yuanjun Wu, Xue Yang, Feng‐Ming Kong, You Lü, Jianxin Xue · 2023 · International Journal of Cancer
85. Regulatory T cell-based therapy in type 1 diabetes: Latest breakthroughs and evidence
    Qiongxiao Huang, Jing Zhu · 2024 · International Immunopharmacology
86. The epigenetic landscape of fate decisions in T cells
    Atishay Jay, Carlos M. Pondevida, Golnaz Vahedi · 2025 · Nature Immunology
87. Viruses Teaching Immunology: Role of LCMV Model and Human Viral Infections in Immunological Discoveries
    Mohamed S. Abdel-Hakeem · 2019 · Viruses
88. Epigenetics of T cell fate decision
    Luigia Pace, Sebastián Amigorena · 2020 · Current Opinion in Immunology
89. The Complex Role of EZH2 in the Tumor Microenvironment: Opportunities and Challenges for Immunotherapy Combinations
    Jing Qiu, Shikhar Sharma, Robert A. Rollins, Thomas A. Paul · 2020 · Future Medicinal Chemistry
90. Epigenetic Features of HIV-Induced T-Cell Exhaustion Persist Despite Early Antiretroviral Therapy
    Genevieve Elizabeth Martin, Debattama R. Sen, Matthew J. Pace, Nicola Robinson, Jodi Meyerowitz, Emily Adland, John Patrick Thornhill, Mathew Jones, Ane Ogbe, Lucia Parolini et al. · 2021 · Frontiers in Immunology
91. Novel Antivirals in Clinical Development for Chronic Hepatitis B Infection
    Lung‐Yi Mak, Wai‐Kay Seto, Man‐Fung Yuen · 2021 · Viruses
92. Molecular and Functional Signatures Associated with CAR T Cell Exhaustion and Impaired Clinical Response in Patients with B Cell Malignancies
    Katia Beider, Orit Itzhaki, Jacob Schachter, Ania Hava Grushchenko-Polaq, Valeria Voevoda-Dimenshtein, Evgenia Rosenberg, Olga Ostrovsky, Olivia Devillers, Ronnie Shapira Frommer, Li‐at Zeltzer et al. · 2022 · Cells
93. Lenvatinib enhances antitumor immunity by promoting the infiltration of TCF1 + CD8 + T cells in HCC via blocking VEGFR2
    Zhibin Mei, Xingxing Gao, Caixu Pan, Qinchuan Wu, Shuai Wang, Junjie Qian, Zhentian Xu, Kangdi Xu, Lin Zhou, Shushen Zhen · 2023 · Cancer Science
94. Current Trends in Neoantigen-Based Cancer Vaccines
    Szu-Ying Ho, Che‐Mai Chang, Hsin-Ni Liao, Wan‐Hsuan Chou, Chin‐Lin Guo, Yun Yen, Yusuke Nakamura, Wei‐Chiao Chang · 2023 · Pharmaceuticals
95. Coengineering specificity, safety, and function into T cells for cancer immunotherapy
    Greta Maria Paola Giordano Attianese, Sarah Ash, Melita B. Irving · 2023 · Immunological Reviews
96. Modeling tumor immunity of mouse glioblastoma by exhausted CD8+ T cells
    Hiroshi Nakashima, Quazim A. Alayo, Pablo Penaloza‐MacMaster, Gordon James Freeman, Vijay Kumar Kuchroo, David A. Reardon, Soledad Fernández, Michael A. Caligiuri, Ennio Antonio Chiocca · 2018 · Scientific Reports
97. Charting the Roadmap of T Cell Exhaustion
    Talyn Chu, Dietmar Zehn · 2020 · Immunity
98. Targeting Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer: Beyond PD-1/PD-L1 Monoclonal Antibodies
    Nicolas Roussot, Courèche Kaderbhaï, François Ghiringhelli · 2025 · Cancers
99. Antigen reactivity defines tissue-resident memory and exhausted T cells in tumors
    Thomas N. Burn, Jan Schröder, Luke C. Gandolfo, Maleika Osman, Elanor N. Wainwright, Enid Y.N. Lam, Keely M. McDonald, Rachel Evans, Shihan Li, Daniel Rawlinson et al. · 2025 · Nature Immunology
100. Translational Biomarkers and Rationale Strategies to Overcome Resistance to Immune Checkpoint Inhibitors in Solid Tumors
     Justin A. Chen, Weijie Ma, Jianda D. Yuan, Tianhong Li · 2020 · Cancer treatment and research